NEW YORK, July 6, 2022 /PRNewswire/ -- As per Zion Market Research study, The global endocrine peptide test market was worth around $7.04 billion in 2021 and is predicted to grow to around $11 billion by 2028 at a CAGR rate of 8% over the forecast period.
Read more at prnewswire.comAt 8% CAGR, Global Endocrine Peptide Test Market Size & Share to Surpass US$ 11 Billion By 2028 | Endocrine Peptide Test | Industry Trends, Share, Growth, Value, Analysis & Forecast Report By Zion Market Research
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here